Cargando…
Epidemiology of type 2 diabetes in India
The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725109/ https://www.ncbi.nlm.nih.gov/pubmed/34708726 http://dx.doi.org/10.4103/ijo.IJO_1627_21 |
_version_ | 1784626046936547328 |
---|---|
author | Pradeepa, Rajendra Mohan, Viswanathan |
author_facet | Pradeepa, Rajendra Mohan, Viswanathan |
author_sort | Pradeepa, Rajendra |
collection | PubMed |
description | The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045. Approximately 57% of these individuals remain undiagnosed. Type 2 diabetes, which accounts for majority of the cases, can lead to multiorgan complications, broadly divided into microvascular and macrovascular complications. These complications are a significant cause for increased premature morbidity and mortality among individuals with diabetes, leading to reduced life expectancy and financial and other costs of diabetes leading to profound economic burden on the Indian health care system. The risk for diabetes is largely influence by ethnicity, age, obesity and physical inactivity, unhealthy diet, and behavioral habits in addition to genetics and family history. Good control of blood sugar blood pressure and blood lipid levels can prevent and/or delay the onset of diabetes complications. The prevention and management of diabetes and associated complications is a huge challenge in India due to several issues and barriers, including lack of multisectoral approach, surveillance data, awareness regarding diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, etc. Thus, effective health promotion and primary prevention, at both, individual and population levels are the need of the hour to curb the diabetes epidemic and reduce diabetes-related complications in India. |
format | Online Article Text |
id | pubmed-8725109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87251092022-01-20 Epidemiology of type 2 diabetes in India Pradeepa, Rajendra Mohan, Viswanathan Indian J Ophthalmol Review Article The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045. Approximately 57% of these individuals remain undiagnosed. Type 2 diabetes, which accounts for majority of the cases, can lead to multiorgan complications, broadly divided into microvascular and macrovascular complications. These complications are a significant cause for increased premature morbidity and mortality among individuals with diabetes, leading to reduced life expectancy and financial and other costs of diabetes leading to profound economic burden on the Indian health care system. The risk for diabetes is largely influence by ethnicity, age, obesity and physical inactivity, unhealthy diet, and behavioral habits in addition to genetics and family history. Good control of blood sugar blood pressure and blood lipid levels can prevent and/or delay the onset of diabetes complications. The prevention and management of diabetes and associated complications is a huge challenge in India due to several issues and barriers, including lack of multisectoral approach, surveillance data, awareness regarding diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, etc. Thus, effective health promotion and primary prevention, at both, individual and population levels are the need of the hour to curb the diabetes epidemic and reduce diabetes-related complications in India. Wolters Kluwer - Medknow 2021-11 2021-10-29 /pmc/articles/PMC8725109/ /pubmed/34708726 http://dx.doi.org/10.4103/ijo.IJO_1627_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Pradeepa, Rajendra Mohan, Viswanathan Epidemiology of type 2 diabetes in India |
title | Epidemiology of type 2 diabetes in India |
title_full | Epidemiology of type 2 diabetes in India |
title_fullStr | Epidemiology of type 2 diabetes in India |
title_full_unstemmed | Epidemiology of type 2 diabetes in India |
title_short | Epidemiology of type 2 diabetes in India |
title_sort | epidemiology of type 2 diabetes in india |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725109/ https://www.ncbi.nlm.nih.gov/pubmed/34708726 http://dx.doi.org/10.4103/ijo.IJO_1627_21 |
work_keys_str_mv | AT pradeeparajendra epidemiologyoftype2diabetesinindia AT mohanviswanathan epidemiologyoftype2diabetesinindia |